A clinical study of ALE1 for hypophosphatasia
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs OC-1 (Primary)
- Indications Hypophosphatasia
- Focus Adverse reactions
- 15 Jan 2025 New trial record
- 08 Jan 2025 According to Alesta Therapeutics media release, company plans this clinical trial in the second half of 2025.